Εμφάνιση απλής εγγραφής

dc.creatorXiromerisiou G., Kalampokini S., Rikos D., Provatas A., Tsouris Z., Markou K., Ralli S., Dardiotis E.en
dc.date.accessioned2023-01-31T11:37:42Z
dc.date.available2023-01-31T11:37:42Z
dc.date.issued2020
dc.identifier10.1016/j.clineuro.2020.106037
dc.identifier.issn03038467
dc.identifier.urihttp://hdl.handle.net/11615/80855
dc.description.abstractGuillain-Barre syndrome (GBS) is the most common cause of acute flaccid paralysis and its incidence increases with age, although all age groups can be affected. The cranial subtypes of GBS account for approximately 5% of cases. Posterior reversible encephalopathy syndrome (PRES) is an acute neurological disorder, mostly reversible but with increased morbidity with permanent neurological sequelae in severe cases. The coexistence of these two syndromes is very rare and underdiagnosed. To the best of our knowledge, there are several dozen cases reported in the literature including ours with the coexistence of these two syndromes in adult patients. We present a rare case of oculopharyngeal type of GBS followed by PRES syndrome. Based on the reviewed cases we discuss various pathogenic mechanisms that support the association between these two entities. This review illustrates the importance of detecting PRES syndrome in the context of acute inflammatory immune-mediated polyneuropathies especially when the patients present early dysautonomia. We also discuss the importance of early administration of immunoglobulin (IVIG) treatment but the possible risks that poses to the occurrence of PRES syndrome as well. © 2020 Elsevier B.V.en
dc.language.isoenen
dc.sourceClinical Neurology and Neurosurgeryen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85087136794&doi=10.1016%2fj.clineuro.2020.106037&partnerID=40&md5=da45e501bd4b1f534c1c402fb527ab39
dc.subjectganglioside antibodyen
dc.subjectganglioside GD 1aen
dc.subjectganglioside GD 1ben
dc.subjectganglioside GD3en
dc.subjectganglioside GM1 antibodyen
dc.subjectganglioside GM1b antibodyen
dc.subjectganglioside GM2 antibodyen
dc.subjectganglioside GQ 1b antibodyen
dc.subjectganglioside GT 1aen
dc.subjectganglioside GT 1ben
dc.subjectimmunoglobulinen
dc.subjectimmunoglobulin G antibodyen
dc.subjectimmunoglobulin M antibodyen
dc.subjectlabetalolen
dc.subjectnitroprusside sodiumen
dc.subjectsulfatideen
dc.subjectunclassified drugen
dc.subjectgangliosideen
dc.subjectimmunoglobulinen
dc.subjectadulten
dc.subjectcase reporten
dc.subjectcerebrospinal fluid analysisen
dc.subjectclinical articleen
dc.subjectcomputer assisted tomographyen
dc.subjectconfusionen
dc.subjectdiplopiaen
dc.subjectdysarthriaen
dc.subjectdysautonomiaen
dc.subjectdysphagiaen
dc.subjectfemaleen
dc.subjectfollow upen
dc.subjectGuillain Barre syndromeen
dc.subjecthallucinationen
dc.subjectheadacheen
dc.subjecthumanen
dc.subjecthypertensionen
dc.subjectmalignant hypertensionen
dc.subjectneuroimagingen
dc.subjectneurologic examinationen
dc.subjectoculopharyngeal variant of Guillain Barre syndromeen
dc.subjectorthostatic hypotensionen
dc.subjectposterior reversible encephalopathy syndromeen
dc.subjectptosis (eyelid)en
dc.subjectReviewen
dc.subjectthin layer chromatographyen
dc.subjecttongueen
dc.subjectweaknessen
dc.subjectcomplicationen
dc.subjectdysautonomiaen
dc.subjectGuillain Barre syndromeen
dc.subjectimmunologyen
dc.subjectposterior reversible encephalopathy syndromeen
dc.subjectAdulten
dc.subjectFemaleen
dc.subjectGangliosidesen
dc.subjectGuillain-Barre Syndromeen
dc.subjectHumansen
dc.subjectImmunoglobulins, Intravenousen
dc.subjectPosterior Leukoencephalopathy Syndromeen
dc.subjectPrimary Dysautonomiasen
dc.subjectElsevier B.V.en
dc.titlePosterior reversible encephalopathy in a GT1a positive oculopharyngeal variant of Guillain-Barré syndrome: A case-report and review of the literatureen
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής